2
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Prostatic Neoplasms
4
Polycystic Ovary Syndrome
4
Uterine Anomalies
1
Salpingitis
1
Progesterone Resistance
1
Primary Ovarian Insufficiency
1
Pregnancy, Ectopic
1
Obesity
1
Leiomyoma
1
Infertility, Female
1
Infertility
1
Hypertension
1
Endometritis
1
Endometriosis
1
Endometrial Neoplasms
1
Endometrial Hyperplasia
1
Interventions
ulipristal acetate
20
Uterine Myomectomy
19
telapristone acetate
18
vilaprisan
12
relugolix
12
Leuprolide
11
Uterine Artery Embolization
10
estradiol, norethindrone drug combination
9
asoprisnil
9
Estradiol
8
elagolix
7
Tranexamic Acid
7
Mifepristone
7
Bupivacaine
7
ulipristal
6
Norethindrone Acetate
6
Hysterectomy
6
Saline Solution
5
linzagolix
4
epigallocatechin gallate
4
Sodium Chloride
4
Misoprostol
4
Letrozole
4
Vitamin B 6
3
Tablets
3
Surveys and Questionnaires
3
Sugars
3
Radiofrequency Ablation
3
Lidocaine
3
Hysteroscopy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Leiomyoma
×
LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)-
×
Clear all
NCT04071574
2023-05-09
CS-EOSP-ICSI
Lebanese University
Phase 1/2
Completed
200 enrolled